Results 141 to 150 of about 44,865 (239)

Comment on: “Challenging the Odds: Long‐Term Survival in Pediatric Diffuse Midline Glioma With H3 K27M and BRAF V600 Co‐Mutations Treated With Upfront Radiotherapy and Targeted Therapy”

Pediatric Blood &Cancer, Volume 73, Issue 5, May 2026.
Natália Dassi, Andrea Maria Cappellano
wiley   +1 more source

THER-17. BRAF-V600E DEGRADATION AS A THERAPEUTIC STRATEGY IN BRAF-V600E MUTANT GLIOMAS [PDF]

Neuro-Oncology, 2019
Guisheng Zhao, Daniel Muldoon, Xiulei Mo, Cong Tang, Haian Fu, W Clay Gustafson, William A Weiss, Theodore Nicolaides   +7 more
openaire   +1 more source

BRAF V600E Negative [PDF]

, 2020
openaire   +1 more source

BRAF V600E Mutation Analysis [PDF]

, 2020
openaire   +1 more source

BRAF V600E Mutation Present [PDF]

, 2020
openaire   +1 more source

BRAF(V600E) Kinase Inhibitor RO5212054 [PDF]

, 2020
openaire   +1 more source

BRAF V600E in thyroid cancer: navigating prognostic uncertainty and therapeutic opportunity. [PDF]

Eur Thyroid J
Riesco-Eizaguirre G.
europepmc   +1 more source

Integrating multimodal management and molecular profiling in a patient with BRAF V600E-positive melanoma and brain metastases. [PDF]

CA Cancer J Clin
Gritsch D, Fadden RM, Mahar MK, Khandsekar MJ, Oh KS, Cahil DP, Dunn GP, Sullivan RJ, Brastianos PK.   +8 more
europepmc   +1 more source

Clinical Images: Erdheim-Chester disease presenting with fever, enlarged lymph nodes, and monoallelic BRAF (V600E) mutation. [PDF]

ACR Open Rheumatol
Gan L, Zhang Q, Yan H, Bai H, Tang X.
europepmc   +1 more source

Exploratory Analysis of Biomarkers and Treatment Outcomes from the COLUMBUS Study in BRAF V600E/K-Mutant Advanced or Metastatic Melanoma. [PDF]

Clin Cancer Res
Dummer R, Deng S, Xie T, Pathan N, Saffari H, Robert C, Arance A, de Groot JWB, Garbe C, Gogas HJ, Gutzmer R, Krajsová I, Liszkay G, Loquai C, Mandala M, Schadendorf D, Yamazaki N, Ascierto PA, Davis CB, Shah K, Hamilton P, di Pietro A, Flaherty K.   +22 more
europepmc   +1 more source